MedPath

A Bilateral Dispensing Comparison of Comfilcon A Over Senofilcon C Contact Lenses

Not Applicable
Completed
Conditions
Astigmatism Bilateral
Interventions
Device: Comfilcon A (test)
Device: Senofilcon C (control)
Registration Number
NCT03684928
Lead Sponsor
Coopervision, Inc.
Brief Summary

The aim of this study is to evaluate the subjective acceptance of Comfilcon A contact lenses when worn on a daily wear modality over one month.

Detailed Description

This study is a 30-subjects prospective, double-masked (investigator and participant), bilateral, randomized, one month cross-over dispensing study comparing subject acceptance of Comfilcon A against Senofilcon A contact lenses.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria

A person is eligible for inclusion in the study if he/she:

  1. Is at least 17 years of age and has full legal capacity to volunteer;
  2. Has had a self-reported oculo-visual examination in the last two years.
  3. Has read and signed an information consent letter;
  4. Is willing and able to follow instructions and maintain the appointment schedule;
  5. Is an adapted soft contact lens wearer, who currently wears contact lenses for a minimum 3 days/week and 8 hours/day AND who anticipates no difficulty wearing CLs for 6 days/week, 10 hours /day.
  6. Is willing to wear contact lens in both eyes for the duration of the study;
  7. Has a minimum astigmatism of - 0.75, determined by refraction;
  8. Can be fit with the two study contact lens types in the powers available;
  9. Has a distance visual acuity of 0.20 logMAR (approx 20/30) or better, determined by refraction;
  10. Can achieve a distance visual acuity of 0.20 logMAR (approx 20/30) or better in each eye with the study contact lenses.
  11. Has clear corneas and no active* ocular disease;
Exclusion Criteria

A person will be excluded from the study if he/she:

  1. Is participating in any concurrent clinical trial;
  2. Has any known active* ocular disease and/or infection;
  3. Has a systemic condition that in the opinion of the investigator may affect a study measure;
  4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study measure;
  5. Has known sensitivity to fluorescein dye or products to be used in the study;
  6. Appears to have any active* ocular pathology, ocular anomaly or severe insufficiency of lacrimal secretion (severe dry eye) that would affect the wearing of contact lenses;
  7. Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
  8. Is aphakic;
  9. Has undergone refractive error surgery;
  10. Has participated in the previous QUENA study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Senofilcon C (control)Senofilcon C (control)Participants were randomized to wear either test or control contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test)Comfilcon A (test)Participants were randomized to wear either test or control contact lenses bilaterally for one month during the cross-over study.
Comfilcon A (test)Senofilcon C (control)Participants were randomized to wear either test or control contact lenses bilaterally for one month during the cross-over study.
Senofilcon C (control)Comfilcon A (test)Participants were randomized to wear either test or control contact lenses bilaterally for one month during the cross-over study.
Primary Outcome Measures
NameTimeMethod
Ease of Insertion(Handling)1 month

Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)

Ease of Insertion (Handling)2 weeks

Subjective ratings of ease of insertion for each pair of lenses (scale: 0-10; 0= Very difficult,10 = Very easy)

Secondary Outcome Measures
NameTimeMethod
Rotational Recovery After Lens Mislocation1 month

Lens relocation after 10 blinks, after 30ยบ rotation mislocation.

Trial Locations

Locations (1)

University Of Waterloo

๐Ÿ‡จ๐Ÿ‡ฆ

Waterloo, Ontario, Canada

ยฉ Copyright 2025. All Rights Reserved by MedPath